FDA facing backlash over decision to halt us of two antibody treatments

ABC NEWS– Pfizer says it is testing an omicron-specific vaccine booster. This comes as the Food and Drug Administration faces backlash over its decision to halt the use of two antibody treatments.

ABC’s Reena Roy has the latest.

Categories: National News